ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer.
Wang J, Zou JX, Xue X, Cai D, Zhang Y, Duan Z, Xiang Q, Yang JC, Louie MC, Borowsky AD, Gao AC, Evans CP, Lam KS, Xu J, Kung HJ, Evans RM, Xu Y, Chen HW.
Wang J, et al. Among authors: zhang y.
Nat Med. 2016 May;22(5):488-96. doi: 10.1038/nm.4070. Epub 2016 Mar 28.
Nat Med. 2016.
PMID: 27019329
Free PMC article.